ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0  AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Session date: 
Tuesday, September 1, 2020 - 3:30pm to 4:30pm
Location: 
Medical College of Wisconsin
8701 Watertown Plank Road
Hub for Collaborative Medicine, Room A7520/7628
Wauwatosa, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

The Medical College of Wisconsin (MCW) has a mission to be the national leader in providing high quality healthcare. One of the ways that we are doing this is to provide high quality continuing medical education (CME) to our faculty; this includes presentation from national leaders in the field of Nephrology. Our education al topics focus on outcomes research in chronic kidney disease and end-stage renal disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard of care, continuing review of kidney biopsy pathology, and basic science research that may become future therapeutics.

Target audience: 

Physicians
Allied Health Care Professionals

Learning objectives: 
  1. Continuing education presentations will include the pathogenesis, diagnoses, and treatment of kidney diseases including but not limited to the following conditions of: hypertension, chronic kidney disease, acute kidney injury, kidney transplant and immunosuppression, glomerulonephritis, nephrotic syndrome, electrolytes disorders and metabolic acidosis and alkalosis.
  2. Attendees will be expected to critically evaluate advances in the field of Nephrology by reviewing studies such as SPRINT for HTN1,4 and improvement in immunosuppression for kidney transplant.6These studies demonstrate safe and effective treatments for kidney related disease and compare outcomes to current standard of care so that clinical practice can be improved. 
  3. Apply newly obtained clinical knowledge to enhance patient care in Nephrology and use this new knowledge to create quality indicators such as control of BP in the CKD population and length of kidney transplant graft survival. These quality indicators can be used monitored to evaluate for performance below national levels (the standard) that would indicate specific areas for improvement.
Faculty & credentials: 

Course Director: Dawn Wolfgram, MD

Presenter:

Alexander Gallan, MD

Assistant Professor

Department of Pathology

 

 

 

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):

Name

Company

Role

Contact

Name: 
Cariann Horstead
Phone number: 
+1 (414) 955-0300